Tag: AMT-060
August 3, 2017
uniQure Gets Back Gene Therapy After Chiesi Ends Partnership
uniQure will regain the rights for their hemophilia B gene therapy as the Chiesi Group backs out from working partnership... July 31, 2017
uniQure Reacquires Rights for Gene Therapy Candidate
uniQure N.V. entered an agreement with Chiesi Group to reacquire the rights to co-develop and commercialize its hemophilia B gene... July 11, 2017
uniQure Presents New Clinical Data in Hemophilia B Patients
uniQure N.V. presented new clinical data from the ongoing Phase I-II trial of AMT-060. April 25, 2017
